We also demonstrated that vaccination of cxcr6-deficient mice induces a defect in the lung recruitment of antigen-specific CD8+ T cells, mostly in the TRM subsets, responsible for a partial loss of cancer vaccine efficacy (12). This evidence concerns the gene CXCR6 and cancer.